Clinical Products Center (CPC) for Studies of Radiation/nuclear Countermeasures Research

根据合同，临床产品中心为所有DAIT资助和/或申办的临床研究项目以及其他NIAID资助的临床试验提供研究产品服务。 将得到支持的研究包括辐射/核对策研究。 此外，根据需要，进行传染病治疗、预防和其他疫苗研究的临床试验。 待研究的试验用药品包括表I至表VI药物制剂、生物制剂和其他制剂。

The Clinical Product Center under contract, provides Investigational Product Services for all DAIT-funded and/or sponsored clinical research programs and other NIAID-funded clinical trials as needed. Studies to be supported include radiation/nuclear countermeasures research. Additionally, and on an as-needed basis, clinical trials of infectious disease treatment, prevention and other vaccine studies. Investigational Products to be studied include schedule I through VI pharmaceutical agents, biologics, and other agents.